Optiver Holding
IMVT icon

Optiver Holding’s Immunovant IMVT Stock Holding History

Optiver Holding’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47K Sell
59
-38
-39% -$984 ﹤0.01% 1970
2025
Q4 		$2.47K Sell
97
-324
-77% -$7.22K ﹤0.01% 1894
2025
Q3 		$6.79K Buy
421
+274
+186% +$4.44K ﹤0.01% 1530
2025
Q2 		$2.35K Buy
+147
New +$2.22K ﹤0.01% 1336

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Optiver Holding's IMVT Position: Q1 2026 in Review

Optiver Holding reduced its Immunovant (IMVT) stake by 39% in Q1 2026, selling an estimated $984 and leaving 59 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Optiver Holding first reported a position in IMVT in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.79K in Q3 2025. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Optiver Holding held 59 shares of Immunovant worth $1.47K as of Q1 2026.
  • Optiver Holding sold 38 Immunovant shares in Q1 2026, an estimated $984.
  • Immunovant made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1970 holding.
  • Optiver Holding first reported a position in Immunovant in Q2 2025 and has held it in 4 quarters since.
  • Optiver Holding's Immunovant position peaked at $6.79K in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.